{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T06:34:36Z","timestamp":1768804476645,"version":"3.49.0"},"reference-count":58,"publisher":"Informa Healthcare","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[1997,4]]},"DOI":"10.1517\/13543784.6.4.427","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T12:49:45Z","timestamp":1115210985000},"page":"427-436","source":"Crossref","is-referenced-by-count":1,"title":["Investigational drugs for eating disorders"],"prefix":"10.1517","volume":"6","author":[{"given":"Scott","family":"Crow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,2,23]]},"reference":[{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820020052007"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(88)90113-8"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1984.01790150040007"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810300068010"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.11.1668"},{"key":"CIT0008","first-page":"852","volume":"49","author":"BREWERTON TD","year":"1992","journal-title":"LESEM MD eta].: Neuroen-docrine responses to m-chlorophenylpiperazine and L-tryptophane in bulimia. Arch. Gen. Psychiatry"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-64-2-203"},{"key":"CIT0010","first-page":"1335","volume":"314","author":"GOLD PW","year":"1986","journal-title":"AVGERINOS PC eta].: Abnor-mal hypothalamic-pituitary-adrenal function in ano-rexia nervosa. New. Engl. J. Med."},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-62-2-319"},{"key":"CIT0012","first-page":"654","volume":"152","author":"O'BRIEN G","year":"1988","journal-title":"The dexametha-sone suppression test in bulimia nervosa. Br. J. Psychia-try"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1987.01800210041007"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-68-3-517"},{"key":"CIT0015","first-page":"190","volume":"296","author":"BOYAR RM","year":"1977","journal-title":"ROFFWARG HL eta].: Cortisolsecretion and metabolism in anorexia nervosa. New. Engl. J. Med."},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.7.1099"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810180048008"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(83)90008-2"},{"key":"CIT0020","first-page":"186","volume":"4","author":"MITCHELL JE","year":"1984","journal-title":"J. Clin. Psychophar-macol."},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1002\/1098-108X(198701)6:1<29::AID-EAT2260060105>3.0.CO;2-2"},{"key":"CIT0022","first-page":"82","volume":"149","author":"AGRAS WS","year":"1992","journal-title":"ARNOW B eta].: Pharmacologic and cognitive-behavioural treatment for bulimia ner-vosa: a controlled clinical comparison. Am. J Psychiatry"},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/ajcn\/53.4.865","volume":"53","author":"ALGER SA","year":"1991","journal-title":"Am. J. Clin. Nutr."},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/070674378803300211","volume":"33","author":"BARLOW J","year":"1988","journal-title":"Can. J. Psychiatry"},{"key":"CIT0026","first-page":"261","volume":"8","author":"BLOUIN AG","year":"1988","journal-title":"PEREZ EL eta].: Treatment of bulimia with fenfluramine and desipramine. j Clin. Psychopharmacol."},{"key":"CIT0028","first-page":"1","volume":"24","author":"FICHTER MM","year":"1991","journal-title":"RIEF W eta].: Fluoxetine versus placebo: a double-blind study with bulimic in-patients undergoing intensive psychotherapy. Pharmacopsychia-try"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.1.67"},{"key":"CIT0030","author":"GOLDBLOOM D","year":"1994","journal-title":"A randomized controlled trial of fluoxetine and individ-ual cognitive behavioural therapy for women with bulimia nervosa: short-term outcome. 6th International Conference on Eating Disorders. New York"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820020059008"},{"key":"CIT0033","first-page":"262","volume":"42","author":"HORNE RL","year":"1988","journal-title":"POPE HG eta].: Treatment ofbulimia with bup rop ion: a multicenter, controlled trial. Clin. Psychiatry"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1986.01800020092012"},{"key":"CIT0035","author":"KANERVA R","year":"1994","journal-title":"Fluoxetine in the treatment ofbulimia nervosa: psychological and behavioural changes after eight weeks' treatment. 6th International Conference on Eating Disorders. New York"},{"key":"CIT0036","first-page":"149","volume":"47","author":"MITCHELL JE","year":"1990","journal-title":"ECKERT ED eta].: A comparisonstudy of antidepressants and structured intensive group psychotherapy in the treatment of bulimia ner-vosa. Arch. Gen. Psychiatry"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.140.1.132"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198505060-00003"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198908000-00004"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1983.tb05866.x"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800290091011"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.9.1206"},{"key":"CIT0044","unstructured":"FARIS PL, HARTMAN BK, KIM SW etal.: Vagal involvementin the pathophysiology of bulimia nervosa: effect of ondansetron on binge\/vomit frequencies and pain de-tection threshold. Eating Disorders Research Society Meet-ing Pittsburgh, Pennsylvania, USA (1996)."},{"issue":"1","key":"CIT0045","first-page":"S146\u2013S159","volume":"11","author":"RUSSELL GFM, CHECKLEY SA, FELDMAN J, EISLER I","year":"1988","journal-title":"Clin. Neuropharmacol"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.134.11.1249"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199106000-00008"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.142.9.1130b"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198904000-00004"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(86)90331-8"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)91513-3"},{"key":"CIT0052","unstructured":"CROWS, MUSSELL M, PETERSON C, MITCHELL J, KNOPKE A: Adequacy of prior treatment in patients wit hbulimia nervosa. 2nd Eating Disorders Research Conference. Pitts-burgh, Pennsylvania, USA (1996)."},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.153.11.1455"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.147.11.1509"},{"key":"CIT0057","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/ajcn\/53.4.865","volume":"53","author":"ALGER SA","year":"1991","journal-title":"Am. J. Clin. Nutt-."},{"key":"CIT0058","first-page":"876","volume":"147","author":"MARCUS MD","year":"1990","journal-title":"EWING L eta].: A double-blind, placebo-controlled trial of fluoxetine plus behaviour modification in the treatment of obese binge-eaters and non-binge-eaters. Am. J. Psychiatry"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1982.tb04501.x"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.144.3.288"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1986.01800020087011"},{"key":"CIT0063","unstructured":"VIGERSKY RA, LORIAUX DL: The effect of cyprohep-tadine in anorexia nervosa: a double-blind trial. In: Anorexia Nervosa. RA Vigersky (Ed.), Raven Press, New York. (1977)."},{"key":"CIT0067","unstructured":"KAYE WH, MCCONAHA C, NAGATA T et al: Fluoxetine prevents relapse in a majority of patients with anorexia nervosa: a double-blind placebo-controlled study. 2nd Eating Disorders Research Conference. Pittsburgh, Pennsyl-vania, USA (1996)."},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810220042005"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91499-2"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608293350901"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1016\/0361-9230(91)90121-Y"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.6.4.427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T16:59:06Z","timestamp":1550422746000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.6.4.427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4]]},"references-count":58,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,2,23]]},"published-print":{"date-parts":[[1997,4]]}},"alternative-id":["10.1517\/13543784.6.4.427"],"URL":"https:\/\/doi.org\/10.1517\/13543784.6.4.427","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,4]]}}}